TSCAN THERAPEUTICS, INC. (TCRX) Free cash flow 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$139.7MFY2025 · since FY2020: -$7.3M → -$139.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$139.7M | -21.9% |
| FY2024 | -$114.6M | -77.7% |
| FY2023 | -$64.5M | +8.8% |
| FY2022 | -$70.7M | -20.7% |
| FY2021 | -$58.6M | -707.3% |
| FY2020 | -$7.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice